Ultragenyx Pharmaceutical, Inc. (RARE)
23.30
-0.61
(-2.55%)
USD |
NASDAQ |
Apr 10, 16:00
23.08
-0.22
(-0.94%)
After-Hours: 20:00
Ultragenyx Pharmaceutical Accounts Payable (Quarterly) : 31.00M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 40.44M |
| Catalyst Pharmaceuticals, Inc. | 11.20M |
| BioMarin Pharmaceutical, Inc. | 312.77M |
| Regeneron Pharmaceuticals, Inc. | 939.00M |
| Xencor, Inc. | 10.83M |